论文部分内容阅读
目的分析米非司酮联合甲氨蝶呤治疗宫外孕患者的疗效。方法 163例宫外孕治疗患者,根据不同的治疗药物分为对照组(76例)与研究组(87例)。对照组单纯予以米非司酮治疗,研究组在对照组基础上予以米非司酮联合甲氨蝶呤治疗,比较两组临床疗效及盆腔包块消失和血β-人绒毛膜促性腺激素(HCG)转阴时间。结果研究组盆腔包块消失和血β-HCG转阴时间分别为(18.12±6.23)、(16.12±6.01)d均短于对照组的(31.85±10.70)、(28.51±8.41)d,差异具有统计学意义(t=10.161、10.918,P<0.05)。研究组临床疗效优于对照组,差异具有统计学意义(P<0.05)。结论米非司酮联合甲氨蝶呤治疗宫外孕可有效减少盆腔包块消失和血β-HCG转阴的时间并提高治疗效果,可在临床推广。
Objective To analyze the efficacy of mifepristone combined with methotrexate in the treatment of ectopic pregnancy. Methods 163 cases of ectopic pregnancy treated patients, divided into control group (76 cases) and study group (87 cases) according to different therapeutic drugs. The control group was treated with mifepristone alone. The study group was given mifepristone combined with methotrexate on the basis of the control group. The clinical efficacy and the disappearance of pelvic mass and β-human chorionic gonadotropin HCG) negative time. Results The disappearance of pelvic mass and the change of blood β-HCG in the study group were (18.12 ± 6.23) days and (16.12 ± 6.01) days, respectively, which were shorter than those in the control group (31.85 ± 10.70) and (28.51 ± 8.41) days respectively, Statistical significance (t = 10.161,10.918, P <0.05). The clinical efficacy of the study group was better than that of the control group, the difference was statistically significant (P <0.05). Conclusion Mifepristone combined with methotrexate in the treatment of ectopic pregnancy can effectively reduce the disappearance of pelvic mass and blood β-HCG negative time and improve the therapeutic effect, which can be clinically promoted.